$2.27T
Total marketcap
$126.98B
Total volume
BTC 49.84%     ETH 15.70%
Dominance

West Pharmaceutical Services, Inc. WPS.F Stock

360.1 EUR {{ price }} 0.027779% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
26.36B EUR
LOW - HIGH [24H]
360.1 - 360.1 EUR
VOLUME [24H]
80 EUR
{{ volume }}
P/E Ratio
48.99
Earnings per share
7.35 EUR

West Pharmaceutical Services, Inc. Price Chart

West Pharmaceutical Services, Inc. WPS.F Financial and Trading Overview

West Pharmaceutical Services, Inc. stock price 360.1 EUR
Previous Close 322.2 EUR
Open 326.4 EUR
Bid 334.2 EUR x 10000
Ask 339.3 EUR x 10000
Day's Range 326.4 - 326.4 EUR
52 Week Range 209.35 - 340.55 EUR
Volume 2 EUR
Avg. Volume 1 EUR
Market Cap 24.38B EUR
Beta (5Y Monthly) 1.093309
PE Ratio (TTM) 48.28402
EPS (TTM) 7.35 EUR
Forward Dividend & Yield 0.69 (0.20%)
Ex-Dividend Date July 25, 2023
1y Target Est 436 EUR

WPS.F Valuation Measures

Enterprise Value 23.69B EUR
Trailing P/E 48.28402
Forward P/E 37.090908
PEG Ratio (5 yr expected) 2.05
Price/Sales (ttm) 8.454309
Price/Book (mrq) 8.723774
Enterprise Value/Revenue 8.216
Enterprise Value/EBITDA 27.394

Trading Information

West Pharmaceutical Services, Inc. Stock Price History

Beta (5Y Monthly) 1.093309
52-Week Change 21.80%
S&P500 52-Week Change 20.43%
52 Week High 340.55 EUR
52 Week Low 209.35 EUR
50-Day Moving Average 321.92 EUR
200-Day Moving Average 270.04 EUR

WPS.F Share Statistics

Avg. Volume (3 month) 1 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 74.24M
Float 73.84M
Short Ratio N/A
% Held by Insiders 0.52%
% Held by Institutions 95.05%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.74
Trailing Annual Dividend Yield 0.22%
5 Year Average Dividend Yield 32.00%
Payout Ratio 0.1015
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 19.14%
Operating Margin (ttm) 25.74%
Gross Margin 38.94%
EBITDA Margin 29.99%

Management Effectiveness

Return on Assets (ttm) 13.21%
Return on Equity (ttm) 21.64%

Income Statement

Revenue (ttm) 2.88B EUR
Revenue Per Share (ttm) 38.74 EUR
Quarterly Revenue Growth (yoy) -0.50%
Gross Profit (ttm) 1.14B EUR
EBITDA 864.8M EUR
Net Income Avi to Common (ttm) 552.1M EUR
Diluted EPS (ttm) 6.76
Quarterly Earnings Growth (yoy) -19.40%

Balance Sheet

Total Cash (mrq) 886.3M EUR
Total Cash Per Share (mrq) 11.94 EUR
Total Debt (mrq) 314.4M EUR
Total Debt/Equity (mrq) 11.33 EUR
Current Ratio (mrq) 3.622
Book Value Per Share (mrq) 37.415

Cash Flow Statement

Operating Cash Flow (ttm) 710.9M EUR
Levered Free Cash Flow (ttm) 264.94M EUR

Profile of West Pharmaceutical Services, Inc.

Country Germany
State PA
City Exton
Address 530 Herman O. West Drive
ZIP 19341-0645
Phone 610 594 2900
Website https://www.westpharma.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 10700

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Q&A For West Pharmaceutical Services, Inc. Stock

What is a current WPS.F stock price?

West Pharmaceutical Services, Inc. WPS.F stock price today per share is 360.1 EUR.

How to purchase West Pharmaceutical Services, Inc. stock?

You can buy WPS.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for West Pharmaceutical Services, Inc.?

The stock symbol or ticker of West Pharmaceutical Services, Inc. is WPS.F.

Which industry does the West Pharmaceutical Services, Inc. company belong to?

The West Pharmaceutical Services, Inc. industry is Medical Instruments & Supplies.

How many shares does West Pharmaceutical Services, Inc. have in circulation?

The max supply of West Pharmaceutical Services, Inc. shares is 73.21M.

What is West Pharmaceutical Services, Inc. Price to Earnings Ratio (PE Ratio)?

West Pharmaceutical Services, Inc. PE Ratio is 48.99320000 now.

What was West Pharmaceutical Services, Inc. earnings per share over the trailing 12 months (TTM)?

West Pharmaceutical Services, Inc. EPS is 7.35 EUR over the trailing 12 months.

Which sector does the West Pharmaceutical Services, Inc. company belong to?

The West Pharmaceutical Services, Inc. sector is Healthcare.